Publications by authors named "Iznaeny Rahma"
Provocative testing using low dose oral flecainide for diagnosis of Brugada syndrome: a report of two cases.
Eur Heart J Case Rep
December 2022
Article Synopsis
- - Brugada syndrome (BrS) is a genetic condition that causes specific changes in heart rhythms, increasing the risk of dangerous heart arrhythmias; it can be diagnosed through an electrocardiogram (ECG) that may require sodium channel blockers like Flecainide to reveal its characteristic patterns.
- - A study highlighted two cases where a lower dose of oral Flecainide (300 mg) effectively unmasked the BrS ECG pattern within 30 minutes, peaking at about 3.5-4.5 hours post-administration, with no serious side effects observed.
- - The results suggest that a smaller dose of Flecainide could be useful in diagnosing BrS, but awareness of potential arrhythmia